Skip to content
Catholic Online Logo

By Catholic Online (NEWS CONSORTIUM)

7/15/2013 (2 years ago)

Catholic Online (www.catholic.org)

Tiny Immunocore of England harnesses T-cells to battle tumors

Two international pharmaceutical giants have their eyes set on a tiny, unassuming British startup company called Immunocore. Housed in a nondescript, single-story business park in Oxfordshire, Immunocore has found a way to use the mighty T-cell to fight tumors, paving the way for a possible cure for cancer.

Dr. Bent Jakobsen began the study T-cells 20 years ago while working at the Medical Research Council's Laboratory of Molecular Biology in Cambridge.

Dr. Bent Jakobsen began the study T-cells 20 years ago while working at the Medical Research Council's Laboratory of Molecular Biology in Cambridge.

Highlights

By Catholic Online (NEWS CONSORTIUM)

Catholic Online (www.catholic.org)

7/15/2013 (2 years ago)

Published in Health

Keywords: Immunocre, T-cells, Bent Jakobsen, immunotherapy, cancer


LOS ANGELES, CA (Catholic Online) - Immunocore has signed contracts with two of the biggest players in the pharmaceuticals industry in the last three weeks. The agreements may soon lead to a huge influx of cash in order to fund research on cancer immunotherapy, using the body's own immune system to fight tumor cells.

It's possible that Immunocore is the only company in the world that has developed a way of harnessing the power of the immune system's natural-born killer cells. T-cells found in the blood cells of humans, designed over millions of years of evolution to seek out and kill invading pathogens.

Executives of the drugs industry, known for their caution in funding research believes that Immunocore may have found a detour in order for future cancer patients are able to fend off their disease with their own immune defenses.

The former academics who set up Immunocore have worked hard on realizing their dream of developing a totally new approach to cancer treatment - and it is beginning to look as if it will finally pay off. "Immunotherapy is radically different," Bent Jakobsen, the Danish-born chief scientific officer of Immunocore says. Jakobsen began the study T-cells 20 years ago while working at the Medical Research Council's Laboratory of Molecular Biology in Cambridge.

"It doesn't do away with the other cancer treatments by any means, but it adds something to the arsenal that has one unique feature - it may have the potency to actually cure cancer," Jakobsen says.

Jakobsen and his colleague's research has piqued the interest of both Genentech in California, owned by the Swiss giant Roche, and Britain's GlaxoSmithKline. Both companies have signed deals with Immunocore that could result in up to half a billion pounds being invested in new cancer treatments based on its unique T-cell therapy.

Cancer immunotherapy, or immuno-oncology as it is technically called, represents a sea change in terms of cancer treatment. Cancer in the past has been largely treated by "slicing," via surgery, "poisoning" via chemotherapy or "burning" via radiotherapy. All three methods are burdened with the inherent problem of how to spare healthy tissue from irreparable damage while ensuring that every cancer cell is killed, deactivated or removed.

The new approach, based on the immune system, a complex web of cells, tissues and organs that constantly strive to keep the body free of disease, which almost certainly includes keeping cancerous cells in check.

Scientists have known for years that the immune system plays a key role in cancer prevention. There is ample evidence of this, not least from patients who are immune-suppressed in some way - they are more likely than other patients to develop cancer.

Many organizations have tried to develop anti-cancer treatments based on antibodies, with limited success, Jakobsen said. Part of the problem is that antibodies are not really designed to recognize cells. Immunocore has built a therapy around the second arm of the immune system, known as cellular immunity, where T-cells seek out and destroy invading pathogens.

"There are a lot of companies working with antibodies but we are virtually the only company in the world that has managed to work with T-cells. It has taken 20 years and from that point we are unique," Jakobsen says.

---


Pope Francis: end world hunger through 'Prayer and Action'


Copywriter 2015 - Distributed by THE NEWS CONSORTIUM

Pope Francis Prayer Intentions for July 2015
Universal:
That political responsibility may be lived at all levels as a high form of charity.
Evangelization: That, amid social inequalities, Latin American Christians may bear witness to love for the poor and contribute to a more fraternal society.



Comments


More Health

The Universal Flu Vaccine: Researchers are closer to a solution that attacks a different part of the virus Watch

Image of Human immune response to influenza is directed against a protein on the virus called hemagglutinin, and a portion of the protein called the hemagglutinin head, where the majority of the mutations occur.

By Catholic Online (NEWS CONSORTIUM)

It's a universal misery that comes whenever the weather cools or it starts to rain. Influenza begins to settle in to a large part of the population, leading to school and job absences. Researchers now say hat attacking a largely hidden part of the influenza ... continue reading


Grandmother miraculously beats eight different cancers in a row Watch

Image of

By Atarah Haely (NEWS CONSORTIUM)

Many people lose hope while battling cancer and experience even more trauma when they fight the same disease again and again. Despite the constant evolution of technology, there are still risks of developing different forms of cancer at any time. However, one ... continue reading


Hepatitis C finally given approval in United Kingdom after 'inexcusable wait' Watch

Image of Sufferer Pamela Anderson claims she got Hepatitis C from her ex-husband Tommy Lee after they shared tattoo needles.

By Catholic Online (NEWS CONSORTIUM)

It comes as wonderful news for untold thousands of Hepatitis C sufferers, albeit one that came after an "Inexcusable wait." The once-a-day drug sofosbuvir has a 90 percent success rate by patients - and will be available free of charge for patients in the ... continue reading


First human brain grown in laboratory dubbed success, despite scientific doubt Watch

Image of

By Talia Ramos (NEWS CONSORTIUM)

For the first time in the history of science, an almost full-grown human brain was successfully grown outside the body and in a laboratory by a team of researchers. According to The Guardian, the brain is a size comparable to that of a 5-week-old fetus. The brain will ... continue reading


Modern Paleo diet may not be so Paleolithic Watch

Image of

By Atarah Haely (NEWS CONSORTIUM)

Carbohydrates, largely overlooked in the modern Paleo diet, were actually a part of the food group consumed by our hunting-and-gathering forefathers, according to a new study published earlier this month. Although the diet works effectively on some trying to lose ... continue reading


Is coffee really good for you? New research finds coffee may reduce risk of some cancers Watch

Image of

By Hannah Marfil (NEWS CONSORTIUM)

Caffeinated coffee drinkers are at a lower risk of having bowel cancer, as well as dying from the disease and other types, according to recent data. Those who drink four to five mugs of coffee a day were found to cut, by almost a half, the odds of bowel cancer ... continue reading


'Brainy' mice research may lead to effective treatment for Alzheimer's Watch

Image of

By Atarah Haely (NEWS CONSORTIUM)

Genetically altered mice tend to be more intelligent and exhibit less anxiety, according to new research. The discovery is speculated to be a part of a more comprehensive study regarding treatment to diseases like Alzheimer's post-traumatic stress disorder (PTSD) and ... continue reading


Study finds intelligence related to a longer lifespan Watch

Image of

By Talia Ramos (NEWS CONSORTIUM)

A longer lifespan is related to intelligence contributed by the genetic makeup, according to new research. Analyzing three twin studies, a research team found that the link between intelligence and a person's life expectancy is about 95 percent because of genetics, ... continue reading


Human Head Transplant: Science fiction or a reality? Watch

Image of

By Nikky Andres (NEWS CONSORTIUM)

Over the years, science fiction has sparked the idea of real life transplant surgeries. The once fantasy of a brain transplant may soon become a reality. MUNTINLUPA, PHILIPPINES (Catholic Online) - When Sergio Canavero, an Italian neurosurgeon, first publicized his ... continue reading


Four-year-old boy with 'butterfly skin' disease lives every day in pain Watch

Image of [Photo by: PA Real Life/Heather Curtis]

By Nikky Andres (NEWS CONSORTIUM)

Somewhere in Charlestown, Indiana lives a young boy whose daily life is filled with agony and pain. Four-year-old Brody Curtis suffers from epidermolysis bullosa (EB), also known as "butterfly disease." The boy's body is full of deep open wounds and has to take several ... continue reading


All Health News

Newsletters

Newsletter Sign Up icon

Stay up to date with the latest news, information, and special offers

Daily Readings

Reading 1, First Thessalonians 3:7-13
7 And so, brothers, your faith has been a great ... Read More

Psalm, Psalms 90:3-4, 12-13, 14, 17
3 You bring human beings to the dust, by saying, ... Read More

Gospel, Matthew 24:42-51
42 'So stay awake, because you do not know the day ... Read More

Saint of the Day

Saint of the Day for August 27th, 2015 Image

St. Monica
August 27: St. Monica was married by arrangement to a pagan official in ... Read More

Inform, Inspire & Ignite Logo

Find Catholic Online on Facebook and get updates right in your live feed.

Become a fan of Catholic Online on Facebook


Follow Catholic Online on Twitter and get News and Product updates.

Follow us on Twitter